1. Home
  2. ABOS vs HNNA Comparison

ABOS vs HNNA Comparison

Compare ABOS & HNNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ABOS
  • HNNA
  • Stock Information
  • Founded
  • ABOS 1996
  • HNNA 1989
  • Country
  • ABOS United States
  • HNNA United States
  • Employees
  • ABOS N/A
  • HNNA N/A
  • Industry
  • ABOS Biotechnology: Pharmaceutical Preparations
  • HNNA Investment Managers
  • Sector
  • ABOS Health Care
  • HNNA Finance
  • Exchange
  • ABOS Nasdaq
  • HNNA Nasdaq
  • Market Cap
  • ABOS 76.9M
  • HNNA 82.4M
  • IPO Year
  • ABOS 2021
  • HNNA N/A
  • Fundamental
  • Price
  • ABOS $1.08
  • HNNA $10.18
  • Analyst Decision
  • ABOS Strong Buy
  • HNNA
  • Analyst Count
  • ABOS 3
  • HNNA 0
  • Target Price
  • ABOS $7.33
  • HNNA N/A
  • AVG Volume (30 Days)
  • ABOS 206.3K
  • HNNA 14.4K
  • Earning Date
  • ABOS 03-27-2025
  • HNNA 05-07-2025
  • Dividend Yield
  • ABOS N/A
  • HNNA 5.54%
  • EPS Growth
  • ABOS N/A
  • HNNA 75.66
  • EPS
  • ABOS N/A
  • HNNA 1.12
  • Revenue
  • ABOS N/A
  • HNNA $33,210,000.00
  • Revenue This Year
  • ABOS N/A
  • HNNA N/A
  • Revenue Next Year
  • ABOS N/A
  • HNNA N/A
  • P/E Ratio
  • ABOS N/A
  • HNNA $9.00
  • Revenue Growth
  • ABOS N/A
  • HNNA 38.27
  • 52 Week Low
  • ABOS $1.05
  • HNNA $6.60
  • 52 Week High
  • ABOS $4.06
  • HNNA $13.88
  • Technical
  • Relative Strength Index (RSI)
  • ABOS 34.99
  • HNNA 38.10
  • Support Level
  • ABOS $1.14
  • HNNA $9.61
  • Resistance Level
  • ABOS $1.28
  • HNNA $10.73
  • Average True Range (ATR)
  • ABOS 0.10
  • HNNA 0.47
  • MACD
  • ABOS -0.01
  • HNNA 0.02
  • Stochastic Oscillator
  • ABOS 6.98
  • HNNA 52.63

About ABOS Acumen Pharmaceuticals Inc.

Acumen Pharmaceuticals Inc is a clinical-stage biopharmaceutical company developing a novel disease-modifying approach to target what it believes to be a key underlying cause of Alzheimer's disease. The company's drug candidate, ACU193, is a subclass monoclonal antibody that selectively targets amyloid-beta oligomers.

About HNNA Hennessy Advisors Inc.

Hennessy Advisors Inc is an investment management company, engaged in the managing and marketing of open-end mutual funds branded as the Hennessy Funds. It offers domestic equity, sectors, and specialty, balanced, and fixed income products. It also provides investment advisory services and shareholder services to the Hennessy Funds which include managing the composition of each fund's portfolio, including the purchase, retention, and disposition of portfolio securities as per the Fund's investment objectives, policies, and restrictions; conducting investment research, and monitoring compliance with each fund's investment restrictions and applicable laws and regulations.

Share on Social Networks: